{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:35:43Z","timestamp":1791012943194,"version":"4.1.0"},"reference-count":280,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1378\/chest.08-0678","type":"journal-article","created":{"date-parts":[[2008,6,23]],"date-time":"2008-06-23T19:37:53Z","timestamp":1214249873000},"page":"546S-592S","source":"Crossref","is-referenced-by-count":557,"special_numbering":"S","title":["Antithrombotic Therapy in Atrial Fibrillation"],"prefix":"10.1016","volume":"133","author":[{"given":"Daniel E.","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren J.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.08-0678_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.297.18.2018","article-title":"Aspirin dose for the prevention of cardiovascular disease: a systematic review","volume":"297","author":"Campbell","year":"2007","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib3","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention; the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1445-5994.1989.tb00271.x","article-title":"Atrial fibrillation and mortality in an elderly population","volume":"19","author":"Lake","year":"1989","journal-title":"Aust NZ J Med"},{"key":"10.1378\/chest.08-0678_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9149(94)90363-8","article-title":"Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)","volume":"74","author":"Furberg","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0025-6196(12)62535-X","article-title":"Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota","volume":"65","author":"Phillips","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1378\/chest.08-0678_bib8","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.0000230607.07928.17","article-title":"Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002)","volume":"37","author":"Lakshminarayan","year":"2006","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","article-title":"Atrial fibrillation: a major contributor to stroke in the elderly; the Framingham Heart Study","volume":"147","author":"Wolf","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib14","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1212\/WNL.40.7.1046","article-title":"Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation","volume":"40","author":"Bogousslavsky","year":"1990","journal-title":"Neurology"},{"key":"10.1378\/chest.08-0678_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bmj.1.5392.1209","article-title":"Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease","volume":"1","author":"Szekely","year":"1964","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0678_bib16","first-page":"817","article-title":"Accuracy of transesophageal echocardiography for identifying left atrial thrombi: a prospective, intraoperative study","volume":"123","author":"Manning","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib17","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2004.05.084","article-title":"Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study","volume":"44","author":"Perez-Gomez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1540-8167.2003.00003.x","volume":"14","author":"Levy","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1378\/chest.08-0678_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib20","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199507063330102","article-title":"Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib25","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib26","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.amjmed.2006.07.034","article-title":"Death and disability from warfarin-associated intracranial and extracranial hemorrhages","volume":"120","author":"Fang","year":"2007","journal-title":"Am J Med"},{"key":"10.1378\/chest.08-0678_bib27","first-page":"1509","article-title":"Stroke Prevention in Atrial Fibrillation II Study","volume":"343","author":"Connolly","year":"1994","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib29","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archinte.159.12.1322","article-title":"Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 Study","volume":"159","author":"Gullov","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib30","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(03)14841-6","article-title":"Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial","volume":"362","author":"Olsson","year":"2003","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.293.6.690","article-title":"Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial","volume":"293","author":"Albers","year":"2005","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib32","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archinte.1996.00440040081009","article-title":"Bleeding during antithrombotic therapy in patients with atrial fibrillation","volume":"156","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.410420606","article-title":"A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin","volume":"42","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1378\/chest.08-0678_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1212\/WNL.53.6.1319","article-title":"Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors","volume":"53","author":"Gorter","year":"1999","journal-title":"Neurology"},{"key":"10.1378\/chest.08-0678_bib36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1532-5415.2006.00828.x","article-title":"Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study","volume":"54","author":"Fang","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1378\/chest.08-0678_bib37","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archinte.165.13.1527","article-title":"Risks of oral anticoagulant therapy with increasing age","volume":"165","author":"Torn","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib38","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjmed.2005.02.022","article-title":"Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall","volume":"118","author":"Gage","year":"2005","journal-title":"Am J Med"},{"key":"10.1378\/chest.08-0678_bib39","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-141-10-200411160-00005","article-title":"Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation","volume":"141","author":"Fang","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib40","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","article-title":"Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient metaanalysis","volume":"288","author":"vanWalraven","year":"2002","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib41","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib42","first-page":"CD001925","article-title":"Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks","author":"Aguilar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.08-0678_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1525-1497.2000.04329.x","article-title":"Prevention of throbomembolism in atrial fibrillation: a metaanalysis of trials of anticoagulants and antiplatelet drugs","volume":"15","author":"Segal","year":"2000","journal-title":"J Gen Intern Med"},{"key":"10.1378\/chest.08-0678_bib44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1052-3057(10)80159-4","article-title":"A differential effect of aspirin in prevention of stroke on atrial fibrillation","volume":"3","year":"1993","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1378\/chest.08-0678_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-8703(99)70259-0","article-title":"Alternate-day dosing of aspiring in atrial fibrillation: lASAF Pilot Study Group","volume":"138","author":"Posada","year":"1999","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1378\/chest.08-0678_bib47","first-page":"112","article-title":"Letter to the editor","volume":"153","author":"Diener","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1378\/chest.08-0678_bib48","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0002-8703(92)90074-6","article-title":"The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"124","author":"Singer","year":"1992","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.STR.0000198839.61112.ee","article-title":"Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial","volume":"37","author":"Sato","year":"2006","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2796.2003.01159.x","article-title":"Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation","volume":"254","author":"Edvardsson","year":"2003","journal-title":"J Intern Med"},{"key":"10.1378\/chest.08-0678_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ageing\/afl129","article-title":"A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)","volume":"36","author":"Rash","year":"2007","journal-title":"Age Ageing"},{"key":"10.1378\/chest.08-0678_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in atrial fibrillation in the elderly community population: the Birmingham Atrial Fibrillation Treatment of the Aged Study (BAFTA), a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib53","first-page":"295","article-title":"The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin [in Chinese]","volume":"34","author":"Hu","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1378\/chest.08-0678_bib54","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.158.14.1513","article-title":"Fixed mini-dose warfarin and aspirin alone and in combination versus adjusted-dose warfarin for stroke prevention in atrial fibrillation: second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study","volume":"158","author":"Gullov","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib55","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/bmj.319.7215.958","article-title":"Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin","volume":"319","author":"Hellemons","year":"1999","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0678_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000016023","article-title":"Cardioembolic versus noncardioemoblic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies","volume":"10","author":"Hart","year":"2000","journal-title":"Cerebrovasc Dis"},{"key":"10.1378\/chest.08-0678_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1212\/WNL.46.1.238","article-title":"Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation Investigators","volume":"46","author":"Miller","year":"1996","journal-title":"Neurology"},{"key":"10.1378\/chest.08-0678_bib58","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Impact of intensity of oral anticoagulation on stroke severity and stroke mortality in patients with non-valvular atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib59","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation: the Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib60","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.STR.28.5.1015","article-title":"Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation","volume":"28","author":"Morocutti","year":"1997","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9149(98)00357-9","article-title":"Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation","volume":"82","author":"Pengo","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib62","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000047711","article-title":"Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation: a randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontane; FFAACS)","volume":"12","author":"Lechat","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1378\/chest.08-0678_bib64","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/eurheartj\/ehi667","article-title":"Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial","volume":"27","author":"Perez-Gomez","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0678_bib65","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM199007193230302","article-title":"The effect of warfarin on mortality and reinfarction after myocardial infarction","volume":"323","author":"Smith","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib66","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial","volume":"360","author":"vanEs","year":"2002","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib68","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ahj.2004.11.015","article-title":"Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study","volume":"149","author":"DiMarco","year":"2005","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib69","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ahj.2006.06.024","article-title":"Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials","volume":"152","author":"Flaker","year":"2006","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000091265","article-title":"Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation: pooled analysis from the SPORTIF III and V studies","volume":"21","author":"Diener","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1378\/chest.08-0678_bib71","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-143-4-200508160-00005","article-title":"Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: metaanalysis with estimates of risk and benefit","volume":"143","author":"Rothberg","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib72","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archinte.165.7.784","article-title":"Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction","volume":"165","author":"Buresly","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib73","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1378\/chest.130.6.1823","article-title":"Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline","volume":"130","author":"Lip","year":"2006","journal-title":"Chest"},{"key":"10.1378\/chest.08-0678_bib74","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.jacc.2005.07.062","article-title":"Trials and tribulations of non-inferiority: the ximelagatran experience","volume":"46","author":"Kaul","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cct.2006.04.005","article-title":"The challenges of new drugs benefits and risks analysis: lessons from the ximelagatran FDA Cardiovascular Advisory Committee","volume":"27","author":"Boudes","year":"2006","journal-title":"Contemp Clin Trials"},{"key":"10.1378\/chest.08-0678_bib76","article-title":"Randomized evaluation of long term anticoagulant therapy (RE-LY) with dabigatran etexilate","year":"2007","journal-title":"National Library of Medicine"},{"key":"10.1378\/chest.08-0678_bib77","article-title":"Once daily rivaroxaban versus adjusted-dose warfarin for prevention of stroke non-valvular atrial fibrillation","year":"2007","journal-title":"National Library of Medicine"},{"key":"10.1378\/chest.08-0678_bib78","article-title":"Apixaban for the prevention of stroke in subjects with atrial fibrillation","year":"2007","journal-title":"National Library of Medicine"},{"key":"10.1378\/chest.08-0678_bib79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.7326\/0003-4819-145-1-200607040-00011","article-title":"Good enough: a primer on the analysis and interpretation of noninferiority trials","volume":"145","author":"Kaul","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib80","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jacc.2006.06.004","article-title":"Trials and tribulations of noninferiority: the ximelagatran experience","volume":"48","author":"Albers","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib81","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2004.09.049","article-title":"State-of-the-art review: oral anticoagulant therapy in atrial fibrillation: the emerging role of direct thrombin inhibition","volume":"45","author":"Halperin","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"10.1378\/chest.08-0678_bib83","first-page":"26a","article-title":"Single and repeated oral dosing of H 376\/95, a prodrug of the direct thrombin inhibitor melagatran, to young healthy male subjects","volume":"94","author":"Eriksson","year":"1999","journal-title":"Blood"},{"key":"10.1378\/chest.08-0678_bib84","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/00003088-200342080-00005","article-title":"Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions","volume":"42","author":"Bredberg","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1378\/chest.08-0678_bib85","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(02)11469-3","article-title":"Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial","volume":"360","author":"Eriksson","year":"2002","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib86","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/archinte.161.18.2215","article-title":"Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study","volume":"161","author":"Heit","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib87","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/eurheartj\/ehl103","article-title":"Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials","volume":"27","author":"Gomberg-Maitland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0678_bib88","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7326\/0003-4819-137-8-200210150-00008","article-title":"Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind trial","volume":"137","author":"Francis","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib89","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-8703(03)00325-9","article-title":"Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V)","volume":"146","author":"Halperin","year":"2003","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib90","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.293.6.736","article-title":"Ximelagatran: promises and concerns","volume":"293","author":"Gurewich","year":"2005","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib92","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1532-5415.1999.tb03004.x","article-title":"Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin","volume":"47","author":"Aronow","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1378\/chest.08-0678_bib93","first-page":"493","article-title":"Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice","volume":"161","author":"Caro","year":"1999","journal-title":"Can Med Assoc J"},{"key":"10.1378\/chest.08-0678_bib94","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archinte.161.11.1443","article-title":"Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?","volume":"161","author":"Evans","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib95","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib96","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00044011-199917060-00009","article-title":"Outcomes of long-term anticoagulation in frail elderly patients with atrial fibrillation","volume":"17","author":"Goldenberg","year":"1999","journal-title":"Clin Drug Invest"},{"key":"10.1378\/chest.08-0678_bib97","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/archinte.1994.00420170093009","article-title":"Anticoagulation in atrial fibrillation: does efficacy in clinical trials translate into effectiveness in practice?","volume":"154","author":"Gottlieb","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib98","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.320.7244.1236","article-title":"Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness","volume":"320","author":"Kalra","year":"2000","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0678_bib99","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/01.STR.31.9.2106","article-title":"Secondary stroke prevention in atrial fibrillation: lessons from clinical practice","volume":"31","author":"Evans","year":"2000","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib100","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/hs1201.099520","article-title":"Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?","volume":"32","author":"Evans","year":"2001","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib101","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2796.2002.01009.x","article-title":"Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice","volume":"252","author":"Frost","year":"2002","journal-title":"J Intern Med"},{"key":"10.1378\/chest.08-0678_bib102","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/eurheartj\/ehl208","article-title":"Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation","volume":"27","author":"Monte","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0678_bib103","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.STR.0000208294.46968.a4","article-title":"Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation","volume":"37","author":"Birman-Deych","year":"2006","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib104","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/hrt.2004.058339","article-title":"Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin","volume":"92","author":"Currie","year":"2006","journal-title":"Heart"},{"key":"10.1378\/chest.08-0678_bib105","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/hrt.2003.023325","article-title":"Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital","volume":"90","author":"Yousef","year":"2004","journal-title":"Heart"},{"key":"10.1378\/chest.08-0678_bib106","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archinte.1997.00440320143013","article-title":"The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from 3 randomized trials","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"issue":"126(suppl)","key":"10.1378\/chest.08-0678_bib107","doi-asserted-by":"crossref","first-page":"429S","DOI":"10.1378\/chest.126.3_suppl.429S","article-title":"Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","author":"Singer","year":"2004","journal-title":"Chest"},{"key":"10.1378\/chest.08-0678_bib108","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/CIRCULATIONAHA.106.177292","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib109","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1212\/WNL.59.7.977","article-title":"An assessment of guidelines for prevention of ischemic stroke","volume":"59","author":"Hart","year":"2002","journal-title":"Neurology"},{"key":"10.1378\/chest.08-0678_bib110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/bmj.316.7130.509","article-title":"Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment","volume":"316","author":"Thomson","year":"1998","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0678_bib111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/01.CIR.102.1.11","article-title":"Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"102","author":"Go","year":"2000","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib112","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1197\/j.aem.2005.04.018","article-title":"Differences among clinical classification schemes for predicting stroke in atrial fibrillation: implications for therapy in daily practice","volume":"12","author":"Laguna","year":"2005","journal-title":"Acad Emerg Med"},{"key":"10.1378\/chest.08-0678_bib113","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/archinte.158.12.1316","volume":"158","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib114","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1052-3057(97)80217-0","article-title":"The Stroke Prevention in Atrial Fibrillation III Study: rationale, design, and patient features","volume":"6","year":"1997","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1378\/chest.08-0678_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-116-1-1","article-title":"Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk","volume":"116","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib116","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","article-title":"Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I\u2013III clinical trials","volume":"30","author":"Hart","year":"1999","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib117","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1052-3057(10)80166-1","article-title":"Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study","volume":"5","year":"1995","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1378\/chest.08-0678_bib118","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.105.553438","article-title":"Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study","volume":"112","author":"Fang","year":"2005","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib119","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","article-title":"A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study","volume":"290","author":"Wang","year":"2003","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.21.1.4","article-title":"Thromboembolic complications in atrial fibrillation","volume":"21","author":"Petersen","year":"1990","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib121","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinte.1981.00340090087019","article-title":"Arterial embolism in thyrotoxicosis with atrial fibrillation","volume":"141","author":"Bar-Sela","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib122","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1445-5994.1981.tb03519.x","article-title":"Atrial fibrillation and arterial embolism in hyperthyroidism","volume":"11","author":"Hurley","year":"1981","journal-title":"Aust NZ J Med"},{"key":"10.1378\/chest.08-0678_bib123","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0002-8703(89)90642-X","article-title":"Thyrotoxicosis, atrial fibrillation, and embolism, revisted","volume":"117","author":"Presti","year":"1989","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib124","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bmj.2.6088.688","article-title":"Arterial embolism in thyrotoxicosis with atrial fibrillation","volume":"2","author":"Staffurth","year":"1977","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0678_bib125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.5694\/j.1326-5377.1979.tb119428.x","article-title":"Embolism in thyrotoxic atrial fibrillation","volume":"1","author":"Yuen","year":"1979","journal-title":"Med J Aust"},{"key":"10.1378\/chest.08-0678_bib126","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/hrt.2005.071555","article-title":"Antithrombotic treatment in atrial fibrillation","volume":"92","author":"Lip","year":"2006","journal-title":"Heart"},{"key":"10.1378\/chest.08-0678_bib127","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"119(suppl)","key":"10.1378\/chest.08-0678_bib128","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1378\/chest.119.1_suppl.194S","article-title":"Antithrombotic therapy in atrial fibrillation","author":"Albers","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.08-0678_bib129","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1161\/01.STR.30.12.2547","article-title":"Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the Stroke Prevention in Atrial Fibrillation III Study","volume":"30","author":"Feinberg","year":"1999","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9343(00)00440-X","article-title":"Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation","volume":"109","author":"Pearce","year":"2000","journal-title":"Am J Med"},{"key":"10.1378\/chest.08-0678_bib131","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib132","article-title":"Applied logistic regression","author":"Hosmer","year":"2000","journal-title":"2nd ed"},{"key":"10.1378\/chest.08-0678_bib133","article-title":"Atrial fibrillation: The management of atrial fibrillation","year":"2007","journal-title":"National Institute for Health and Clinical Excellence"},{"key":"10.1378\/chest.08-0678_bib134","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000236840.00467.84","article-title":"Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation","volume":"37","author":"Lip","year":"2006","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/0003-4819-128-8-199804150-00004","article-title":"Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation","volume":"128","author":"Stollberger","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib136","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-128-8-199804150-00005","article-title":"Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation","volume":"128","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib137","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib138","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000033220.97592.9A","article-title":"Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors","volume":"106","author":"Conway","year":"2002","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib139","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1026192301848","article-title":"Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study","volume":"15","author":"Go","year":"2003","journal-title":"J Thromb Thrombolysis"},{"key":"10.1378\/chest.08-0678_bib140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000083815","article-title":"Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice","volume":"33","author":"Choudhury","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1378\/chest.08-0678_bib141","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","article-title":"Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation","volume":"107","author":"Conway","year":"2003","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib142","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1001\/jama.1985.03360240061035","article-title":"Characteristics and prognosis of lone atrial fibrillation: 30 year follow-up in the Framingham study","volume":"254","author":"Brand","year":"1985","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib143","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","article-title":"Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy","volume":"35","author":"Hart","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib144","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1067\/mhj.2002.122875","volume":"143","year":"2002","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib145","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.0000051455.44919.73","article-title":"Asymptomatic or \u201csilent\u201d atrial fibrillation: frequency in untreated patients and patients receiving azimilide","volume":"107","author":"Page","year":"2003","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib146","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","article-title":"Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia","volume":"89","author":"Page","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib147","first-page":"23","article-title":"Editorial comments: epidemiology of atrial fibrillation and flutter","author":"Pritchett","year":"1995","journal-title":"Atrial arrhythmias: state of the art"},{"key":"10.1378\/chest.08-0678_bib148","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archinte.165.10.1185","article-title":"Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study","volume":"165","author":"Sherman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib149","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","article-title":"Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers","volume":"46","author":"Capucci","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib150","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib151","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1161\/01.STR.0000181115.59173.42","article-title":"Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack","volume":"36","author":"Arima","year":"2005","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib152","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/eurheartj\/ehl504","article-title":"Effect of hypertension on anticoagulated patients with atrial fibrillation","volume":"28","author":"Lip","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0678_bib153","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJM199608223350802","article-title":"An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation","volume":"335","author":"Hylek","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib154","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/01.STR.28.12.2382","article-title":"Warfarin use among patients with atrial fibrillation","volume":"28","author":"Brass","year":"1997","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","article-title":"Optimal oral anticoagulant therapy in patients with mechanical heart valves","volume":"333","author":"Cannegieter","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib156","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib157","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1474-4422(06)70536-1","article-title":"Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study","volume":"5","author":"O'Donnell","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1378\/chest.08-0678_bib158","doi-asserted-by":"crossref","first-page":"970","DOI":"10.7326\/0003-4819-124-11-199606010-00004","article-title":"The risk for and severity of bleeding complications in elderly patients treated with warfarin","volume":"124","author":"Fihn","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib159","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib160","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archinte.1993.00410130073007","article-title":"Bleeding complications in oral anticoagulant therapy: an analysis of risk factors","volume":"153","author":"van derMeer","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib161","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1001\/archinte.1996.00440150095011","article-title":"Warfarin for atrial fibrillation: the patient's perspective","volume":"156","author":"Man-Son-Hing","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7323.1218","article-title":"Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation","volume":"323","author":"Devereaux","year":"2001","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0678_bib163","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.282.8.737","article-title":"A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial","volume":"282","author":"Man-Son-Hing","year":"1999","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib164","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/archinte.1996.00440150083009","article-title":"The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life","volume":"156","author":"Gage","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib165","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.STR.25.9.1721","article-title":"Patient preferences for stroke outcomes","volume":"25","author":"Solomon","year":"1994","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib166","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1258\/jrsm.96.4.175","article-title":"Patients' understanding of anticoagulant therapy in a multiethnic population","volume":"96","author":"Nadar","year":"2003","journal-title":"J R Soc Med"},{"key":"10.1378\/chest.08-0678_bib167","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.158.15.1669","article-title":"Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation","volume":"158","author":"Eckman","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib168","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jama.1995.03530230025025","article-title":"Cost- effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation","volume":"274","author":"Gage","year":"1995","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib169","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0272989X05280558","article-title":"Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making","volume":"25","author":"Man-Son-Hing","year":"2005","journal-title":"Med Decis Making"},{"key":"10.1378\/chest.08-0678_bib170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archinte.164.1.55","article-title":"National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation","volume":"164","author":"Fang","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib171","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib172","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/eurheartj\/ehl146","article-title":"Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study)","volume":"27","author":"Friberg","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0678_bib173","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1368-5031.2006.00790.x","article-title":"Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice","volume":"60","author":"Boulanger","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1378\/chest.08-0678_bib174","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/hrt.75.2.200","article-title":"Physician variation in the management of patients with atrial fibrillation","volume":"75","author":"Lip","year":"1996","journal-title":"Heart"},{"key":"10.1378\/chest.08-0678_bib175","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.STR.0000209239.71702.ce","article-title":"Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial Fibrillation","volume":"37","author":"Hylek","year":"2006","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib176","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1001\/archinte.164.18.2044","article-title":"Safety of anticoagulation therapy in well-informed older patients","volume":"164","author":"Kagansky","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib177","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/eurheartj\/ehl015","article-title":"Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation","volume":"27","author":"Nieuwlaat","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0678_bib178","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1525-1497.2001.10432.x","article-title":"Is warfarin really underused in patients with atrial fibrillation?","volume":"16","author":"Weisbord","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1378\/chest.08-0678_bib179","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2169\/internalmedicine.40.1183","article-title":"Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation","volume":"40","author":"Yasaka","year":"2001","journal-title":"Intern Med"},{"key":"10.1378\/chest.08-0678_bib180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1253\/circj.68.417","article-title":"Attitudes of Japanese cardiologists toward anticoagulation for nonvalvular atrial fibrillation and reasons for its underuse","volume":"68","author":"Inoue","year":"2004","journal-title":"Circ J"},{"key":"10.1378\/chest.08-0678_bib181","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2169\/internalmedicine.43.553","article-title":"Physicians' attitudes toward anticoagulant therapy in patients with chronic atrial fibrillation","volume":"43","author":"Maeda","year":"2004","journal-title":"Intern Med"},{"key":"10.1378\/chest.08-0678_bib182","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib183","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0678_bib184","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0735-1097(96)00551-7","article-title":"Left atrial appendage \u201cstunning\u201d after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events","volume":"29","author":"Grimm","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib185","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/euhj.2000.2427","article-title":"Thromboembolic risk in atrial flutter: the FLASIEC (FLutterAtrialeSocietaIaliana diEcografiaCardiovascolare) multicentre study","volume":"22","author":"Corrado","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0678_bib186","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0735-1097(01)01463-2","article-title":"Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance","volume":"38","author":"Schmidt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib187","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0002-9149(98)00555-4","article-title":"Acute changes in spontaneous echo contrast and atrial function after cardioversion of persistent atrial flutter","volume":"82","author":"Weiss","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib188","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0002-9149(99)80058-7","article-title":"Prevalence of intraatrial thrombus in patients with atrial flutter","volume":"76","author":"Bikkina","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib189","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0735-1097(97)00326-4","article-title":"Thromboembolism in chronic atrial flutter: is the risk underestimated?","volume":"30","author":"Lanzarotti","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib190","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0002-9149(98)00419-6","article-title":"Risk of thromboembolic events in patients with atrial flutter","volume":"82","author":"Seidl","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib191","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0003-4975(93)90894-N","article-title":"Hazards of postoperative atrial arrhythmias","volume":"56","author":"Creswell","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.08-0678_bib192","first-page":"III236","article-title":"Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a metaanalysis of randomized control trials","volume":"84","author":"Andrews","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib193","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5223(19)35525-4","article-title":"The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting","volume":"100","author":"Leitch","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.08-0678_bib194","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5223(19)36793-5","article-title":"Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass","volume":"101","author":"Hashimoto","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.08-0678_bib195","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0033-0620(89)90031-5","article-title":"Atrial fibrillation following coronary artery bypass surgery","volume":"31","author":"Lauer","year":"1989","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1378\/chest.08-0678_bib196","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0003-4975(93)90871-E","article-title":"A perspective of postoperative atrial fibrillation in cardiac operations","volume":"56","author":"Cox","year":"1993","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.08-0678_bib197","first-page":"798","article-title":"Clinical outcome of patients who develop atrial fibrillation after coronary artery bypass graft surgery","volume":"18","author":"Stebbins","year":"1995","journal-title":"PACE"},{"key":"10.1378\/chest.08-0678_bib198","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.CIR.60.3.665","article-title":"Characterization of atrial flutter: studies in man after open heart surgery using fixed atrial electrodes","volume":"60","author":"Wells","year":"1979","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib199","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/01.CIR.94.3.390","article-title":"Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources","volume":"94","author":"Aranki","year":"1996","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib200","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1053\/euhj.1997.0838","article-title":"Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol","volume":"19","author":"Weber","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.08-0678_bib201","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/01.CIR.88.6.2618","article-title":"Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery","volume":"88","author":"Steinberg","year":"1993","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib202","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00000542-200109000-00018","article-title":"Use of intraoperative transesophageal echocardiography to predict atrial fibrillation after coronary artery bypass grafting","volume":"95","author":"Shore-Lesserson","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1378\/chest.08-0678_bib203","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jama.1996.03540040044031","article-title":"Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization; MultiCenter Study of Perioperative Ischemia Research Group","volume":"276","author":"Mathew","year":"1996","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib204","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1161\/01.STR.32.7.1508","article-title":"Stroke after coronary artery bypass: incidence, predictors, and clinical outcome","volume":"32","author":"Stamou","year":"2001","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib205","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.STR.30.3.514","article-title":"Cerebral injury after cardiac surgery: identification of a group at extraordinary risk; Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators","volume":"30","author":"Wolman","year":"1999","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib206","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0003-4975(99)01309-0","article-title":"Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting","volume":"69","author":"John","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.08-0678_bib207","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJM198811103191903","article-title":"Stroke following coronary-artery bypass surgery: a case-control estimate of the risk from carotid bruits","volume":"319","author":"Reed","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib208","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0022-5223(19)33877-2","article-title":"Differential effects of advanced age on neurologic and cardiac risks of coronary artery operations","volume":"104","author":"Tuman","year":"1992","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.08-0678_bib209","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1056\/NEJM199612193352501","article-title":"Adverse cerebral outcomes after coronary bypass surgery: Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators","volume":"335","author":"Roach","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib210","doi-asserted-by":"crossref","first-page":"II85","DOI":"10.1161\/01.CIR.92.9.85","article-title":"Outcomes of coronary artery bypass graft surgery in 24,461 patients aged 80 years or older","volume":"92","author":"Peterson","year":"1995","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib211","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0002-9149(87)91045-9","article-title":"Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting","volume":"60","author":"Taylor","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib212","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0003-4975(95)00885-3","article-title":"Thoracoscopic obliteration of the left atrial appendage: potential for stroke reduction?","volume":"61","author":"Odell","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.08-0678_bib213","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0003-4975(95)01106-4","article-title":"Obliteration of the left atrial appendage: a concept worth testing","volume":"61","author":"Lindsay","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.08-0678_bib214","article-title":"Left atrial appendage: our most lethal human attachment; surgical implications","author":"Johnson","year":"1999","journal-title":"European Association of Cardiothoracic Surgery"},{"key":"10.1378\/chest.08-0678_bib215","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0735-1097(03)00953-7","article-title":"Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation","volume":"42","author":"Blackshear","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib216","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0735-1097(03)00958-6","article-title":"Obliteration of the left atrial appendage for prevention of thromboembolism","volume":"42","author":"Halperin","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib217","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ahj.2004.09.054","article-title":"Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke","volume":"150","author":"Healey","year":"2005","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib218","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0735-1097(03)00954-9","article-title":"Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study","volume":"42","author":"Garcia-Fernandez","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib219","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-5223(19)36685-1","article-title":"The surgical treatment of atrial fibrillation: IV. Surgical technique","volume":"101","author":"Cox","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.08-0678_bib220","first-page":"548","article-title":"New method for terminating cardiac arrhythmias","volume":"182","author":"Lown","year":"1962","journal-title":"JAMA"},{"key":"10.1378\/chest.08-0678_bib221","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/hrt.29.4.469","article-title":"Electrical reversion of cardiac arrhythmias","volume":"29","author":"Lown","year":"1967","journal-title":"Br Heart J"},{"key":"10.1378\/chest.08-0678_bib222","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0002-9149(69)90068-X","article-title":"The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation","volume":"23","author":"Bjerkelund","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib223","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-65-2-216","article-title":"Electrical cardioversion of atrial fibrillation: immediate and long-term results and selection of patients","volume":"65","author":"Morris","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib224","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0735-1097(92)90530-Z","article-title":"Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter","volume":"19","author":"Arnold","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib225","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/hrt.29.6.926","article-title":"Complication in 220 patients with cardiac dysrhythmias treated by phased DC schock and indications for electroconversion","volume":"29","author":"Resnekov","year":"1967","journal-title":"Br Heart J"},{"key":"10.1378\/chest.08-0678_bib226","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/hrt.31.4.496","article-title":"Prognosis of atrial arrhythmias treated by electrical countershock therapy: a three-year follow-up","volume":"31","author":"McCarthy","year":"1969","journal-title":"Br Heart J"},{"key":"10.1378\/chest.08-0678_bib227","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0002-9149(98)00704-8","article-title":"Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis","volume":"82","author":"Berger","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib228","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1525-2167(03)00075-1","article-title":"Prevalence of atrial thrombi in patients with atrial fibrillation\/flutter and subtherapeutic anticoagulation prior to cardioversion","volume":"5","author":"Corrado","year":"2004","journal-title":"Eur J Echocardiogr"},{"key":"10.1378\/chest.08-0678_bib229","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0033-0620(60)80005-9","article-title":"The management of chronic atrial fibrillation: indications and method of conversion to sinus rhythm","volume":"2","author":"Goldman","year":"1959","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1378\/chest.08-0678_bib230","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0735-1097(02)01785-0","article-title":"Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion: final results of the Ludwigshafen Observational Cardioversion Study","volume":"39","author":"Seidl","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib231","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0735-1097(02)02052-1","article-title":"Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion","volume":"40","author":"Gallagher","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib232","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-126-3-199702010-00004","article-title":"Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study; a randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography","volume":"126","author":"Klein","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib233","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.115.1.140","article-title":"Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation","volume":"115","author":"Corrado","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.08-0678_bib234","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.CIR.92.2.160","article-title":"Cardioversion of nonrheumatic atrial fibrillation: reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution","volume":"92","author":"Collins","year":"1995","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib235","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0002-8703(95)90253-8","article-title":"Left atrial appendage \u201cstunning\u201d after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography","volume":"130","author":"Grimm","year":"1995","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib236","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0735-1097(93)90543-A","article-title":"Impact of electrical cardioversion of atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography","volume":"22","author":"Grimm","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib237","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/hrt.78.3.250","article-title":"Left atrial appendage function in patients with atrial flutter","volume":"78","author":"Omran","year":"1997","journal-title":"Heart"},{"key":"10.1378\/chest.08-0678_bib238","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0735-1097(94)00396-8","article-title":"Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study","volume":"25","author":"Stoddard","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib239","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0735-1097(89)90602-5","article-title":"Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation","volume":"13","author":"Manning","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-8703(90)90079-D","article-title":"Return of atrial mechanical function following electrical conversion of atrial dysrhythmias","volume":"120","author":"O'Neill","year":"1990","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib241","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJM199303183281102","article-title":"Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi","volume":"328","author":"Manning","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib242","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0894-7317(99)70107-0","article-title":"When the body and appendage of the left atrium disagree: \u201cfocal\u201d atrial fibrillation; implications for atrial thrombus formation and risk of thromboembolism","volume":"12","author":"Seto","year":"1999","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1378\/chest.08-0678_bib243","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/0002-9149(88)90260-3","article-title":"Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm","volume":"62","author":"Shapiro","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib244","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/0735-1097(94)90652-1","article-title":"Impaired left atrial mechanical function after cardioversion: relationship to the duration of atrial fibrillation","volume":"23","author":"Manning","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib245","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/0735-1097(94)00560-D","article-title":"Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5 year study","volume":"25","author":"Manning","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib246","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0002-9149(97)89406-4","article-title":"Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus","volume":"77","author":"Fatkin","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib247","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/0002-8703(95)90405-0","article-title":"Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation","volume":"129","author":"Stoddard","year":"1995","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib248","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0735-1097(96)00448-2","article-title":"Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation","volume":"29","author":"Seto","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib249","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2003.11.030","article-title":"Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks","volume":"43","author":"Klein","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib250","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.echo.2004.09.022","article-title":"Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging","volume":"18","author":"Bernhardt","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1378\/chest.08-0678_bib251","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.89.6.2509","article-title":"Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: a multicenter study [see comments]","volume":"89","author":"Black","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib252","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-8703(93)91054-I","article-title":"Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients","volume":"126","author":"Black","year":"1993","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib253","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-8703(95)90045-4","article-title":"Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials","volume":"129","author":"Moreyra","year":"1995","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib254","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/0002-8703(93)90430-H","article-title":"Cerebral thromboembolization after cardioversion of atrial fibrillation in patients without transesophageal echocardiographic findings of left atrial thrombus","volume":"126","author":"Salka","year":"1993","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib255","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ahj.2005.07.011","article-title":"Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial","volume":"151","author":"Klein","year":"2006","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib256","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0002-9343(01)00716-1","article-title":"Transesophageal-echocardiography-facilitated early cardioversion from atrial fibrillation: short-term safety and impact on maintenance of sinus rhythm at 1 year","volume":"110","author":"Weigner","year":"2001","journal-title":"Am J Med"},{"key":"10.1378\/chest.08-0678_bib257","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.amjmed.2005.06.029","article-title":"Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion","volume":"119","author":"Wu","year":"2006","journal-title":"Am J Med"},{"key":"10.1378\/chest.08-0678_bib258","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijcard.2004.05.052","article-title":"Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up","volume":"102","author":"deLuca","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1378\/chest.08-0678_bib259","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/europace\/eul034","article-title":"Clinical practicality and predictive value of transoesophageal echocardiography in early cardioversion of atrial fibrillation","volume":"8","author":"Strandberg","year":"2006","journal-title":"Europace"},{"key":"10.1378\/chest.08-0678_bib260","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0002-8703(03)00390-9","article-title":"Transesophageal echocardiography before cardioversion of recurrent atrial fibrillation: does absence of previous atrial thrombi preclude the need of a repeat test?","volume":"146","author":"Shen","year":"2003","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib261","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7326\/0003-4819-126-8-199704150-00005","article-title":"Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours","volume":"126","author":"Weigner","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0678_bib262","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0002-9149(97)89328-9","article-title":"Direct-current cardioversion for the conversion of atrial flutter","volume":"77","author":"Chalasani","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib263","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9343(01)00902-0","article-title":"Thromboembolic complications after electrical cardioversion in patients with atrial flutter","volume":"111","author":"Elhendy","year":"2001","journal-title":"Am J Med"},{"key":"10.1378\/chest.08-0678_bib264","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.95.4.962","article-title":"Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter: a prospective study using transesophageal echocardiography","volume":"95","author":"Irani","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9149(93)90711-K","article-title":"Delayed restoration of atrial function after conversion of atrial flutter by pacing or electrical cardioversion","volume":"71","author":"Jordaens","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib266","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1378\/chest.110.4.1001","article-title":"Thromboembolism following cardioversion of \u201ccommon\u201d atrial flutter: risk factors and limitations of transesophageal echocardiography","volume":"110","author":"Mehta","year":"1996","journal-title":"Chest"},{"key":"10.1378\/chest.08-0678_bib267","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0002-9149(97)00044-1","article-title":"Risk of thromboembolism in chronic atrial flutter","volume":"79","author":"Wood","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib268","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib269","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"VanGelder","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib270","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0735-1097(02)01800-4","article-title":"Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation","volume":"39","author":"Antonielli","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0678_bib271","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/archinte.1995.00430170081010","article-title":"Treatment of resistant atrial fibrillation: a metaanalysis comparing amiodarone and flecainide","volume":"155","author":"Zarembski","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0678_bib272","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF); a randomised trial","volume":"356","author":"Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0678_bib273","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ahj.2006.02.016","article-title":"Asymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT)","volume":"152","author":"Hohnloser","year":"2006","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0678_bib274","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-006-7622-y","article-title":"Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study","volume":"15","author":"Glotzer","year":"2006","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1378\/chest.08-0678_bib275","doi-asserted-by":"crossref","first-page":"9K","DOI":"10.1016\/S0002-9149(00)01186-3","article-title":"Mapping-guided ablation of pulmonary veins to cure atrial fibrillation","volume":"86","author":"Haissaguerre","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0678_bib276","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0678_bib277","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1161\/CIRCULATIONAHA.104.491530","article-title":"Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies","volume":"111","author":"Karch","year":"2005","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib278","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.CIR.0000157153.30978.67","article-title":"Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"111","author":"Cappato","year":"2005","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib279","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0678_bib280","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.STR.31.4.817","volume":"31","author":"Yamaguchi","year":"2000","journal-title":"Stroke"},{"key":"10.1378\/chest.08-0678_bib281","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0002-8703(03)00324-7","article-title":"Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality","volume":"146","author":"Gomberg-Maitland","year":"2003","journal-title":"Am Heart J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369208601257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369208601257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T11:21:43Z","timestamp":1588764103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369208601257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":280,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0012369208601257"],"URL":"https:\/\/doi.org\/10.1378\/chest.08-0678","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}